Keryx Biopharmaceuticals Email Format
Biotechnology ResearchMassachusetts, United States51-200 Employees
As of December 13, 2018, Keryx Biopharmaceuticals and Akebia Therapeutics have merged and are now moving forward as one fully integrated company named Akebia, focused on developing and delivering therapies to patients with chronic kidney disease. For future news and updates, please follow Akebia - https://www.linkedin.com/company/akebia-therapeutics/.